• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估哮喘和 COPD 患者的患者报告结局:在临床实践中可以推荐哪些?

Assessing patient-reported outcomes in asthma and COPD patients: which can be recommended in clinical practice?

机构信息

Department of General Practice and Elderly Care Medicine, University of Groningen, University Medical Center Groningen.

University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, The Netherlands.

出版信息

Curr Opin Pulm Med. 2018 Jan;24(1):18-23. doi: 10.1097/MCP.0000000000000447.

DOI:10.1097/MCP.0000000000000447
PMID:29084018
Abstract

PURPOSE OF REVIEW

There is a clear need for simple and reliable patient-reported outcome measures for chronic obstructive pulmonary disease (COPD) and asthma in daily practice. The purpose of this review is to facilitate the choice for clinicians of patient-reported outcomes which they can use in their daily practice.

RECENT FINDINGS

More than 50 patient-reported outcome measures for asthma and COPD exist and clinicians are often left confused on which to use. Four tools (two for asthma and two for COPD) can be suggested based on validity/reliability, responsiveness, practicality and are particularly convenient in terms of time to measure.

SUMMARY

On the basis of ample evidence, the COPD assessment test and the clinical COPD questionnaire for COPD and asthma control questionnaire and the asthma control test for asthma can be recommended for use in both primary care and other clinical settings. A simple guide figured as smiley faces has been designed to assist physicians to easily select the appropriate measure. With the current direction of thinking into treatable traits, targeted measures that evaluate the upper airways like the control of allergic rhinitis and asthma test may also be more used in the future.

摘要

目的综述

在日常实践中,慢性阻塞性肺疾病(COPD)和哮喘患者需要简单可靠的患者报告结局测量方法。本综述的目的是为临床医生提供便利,帮助他们在日常实践中选择合适的患者报告结局测量方法。

最近发现

目前已有超过 50 种用于哮喘和 COPD 的患者报告结局测量方法,临床医生常常感到困惑,不知道该选择哪种方法。基于有效性/可靠性、反应性、实用性以及测量时间的便利性,有 4 种工具(哮喘和 COPD 各 2 种)可供推荐。

总结

基于充分的证据,可以推荐 COPD 评估测试和临床 COPD 问卷用于 COPD,哮喘控制问卷和哮喘控制测试用于哮喘,无论在初级保健还是其他临床环境中均可使用。设计了一个简单的笑脸指南,以帮助医生轻松选择合适的测量方法。随着可治疗特征的当前思维方向,未来可能会更多地使用评估上呼吸道的靶向测量方法,如过敏性鼻炎和哮喘控制测试。

相似文献

1
Assessing patient-reported outcomes in asthma and COPD patients: which can be recommended in clinical practice?评估哮喘和 COPD 患者的患者报告结局:在临床实践中可以推荐哪些?
Curr Opin Pulm Med. 2018 Jan;24(1):18-23. doi: 10.1097/MCP.0000000000000447.
2
Respiratory and allergic diseases: from upper respiratory tract infections to asthma.呼吸道和过敏性疾病:从上呼吸道感染到哮喘。
Prim Care. 2002 Jun;29(2):231-61. doi: 10.1016/s0095-4543(01)00008-2.
3
Treatable traits of chronic airways disease.慢性气道疾病的可治疗特征。
Curr Opin Pulm Med. 2018 Jan;24(1):24-31. doi: 10.1097/MCP.0000000000000445.
4
Precision medicine and treatable traits in chronic airway diseases - where do we stand?精准医学与慢性气道疾病的可治疗特征 - 我们处于什么位置?
Curr Opin Pulm Med. 2020 Jan;26(1):33-39. doi: 10.1097/MCP.0000000000000639.
5
Hypoventilation in asthma and chronic obstructive pulmonary disease.哮喘和慢性阻塞性肺疾病中的通气不足。
Semin Respir Crit Care Med. 2009 Jun;30(3):321-9. doi: 10.1055/s-0029-1222446. Epub 2009 May 18.
6
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.慢性气道评估测试:在哮喘和/或 COPD 患者中的心理测量特性。
Respir Res. 2023 Apr 8;24(1):106. doi: 10.1186/s12931-023-02394-6.
7
Airflow obstruction: is it asthma or is it COPD?气流阻塞:是哮喘还是慢性阻塞性肺疾病?
Int J Chron Obstruct Pulmon Dis. 2016 Nov 30;11:3007-3013. doi: 10.2147/COPD.S54927. eCollection 2016.
8
Monitoring pulmonary function in asthma and COPD: point-of-care testing.哮喘和慢性阻塞性肺疾病中肺功能的监测:即时检测
Ann Pharmacother. 2004 Jan;38(1):126-33. doi: 10.1345/aph.1D230.
9
Stage 1 development of a patient-reported experience measure (PREM) for chronic obstructive pulmonary disease (COPD).患者报告的慢性阻塞性肺疾病(COPD)体验量表(PREM)的第一阶段开发。
NPJ Prim Care Respir Med. 2017 Jul 24;27(1):47. doi: 10.1038/s41533-017-0047-5.
10
Global initiative for chronic obstructive lung disease for chronic obstructive pulmonary disease: GOLD opportunity for lung disorders.慢性阻塞性肺疾病全球倡议:慢性阻塞性肺疾病的黄金机遇与肺部疾病。
Prev Med. 2005 Mar;40(3):274-7. doi: 10.1016/j.ypmed.2004.06.010.

引用本文的文献

1
Exploring the feasibility, acceptability, usability and safety of a digitally supported self-management intervention for uncontrolled asthma: A pre-post pilot study in secondary care.探索针对控制不佳哮喘的数字支持自我管理干预措施的可行性、可接受性、可用性和安全性:一项二级医疗中的前后对照预试验研究
Digit Health. 2024 Nov 5;10:20552076241292391. doi: 10.1177/20552076241292391. eCollection 2024 Jan-Dec.
2
Assessing the prevalence and severity of asthma, rhinitis, and eczema among schoolchildren (6-7 and 13-14 years old) in Khuzestan, Iran: a cross-sectional survey.评估伊朗胡齐斯坦省(6-7 岁和 13-14 岁)学童(儿童)哮喘、鼻炎和湿疹的流行率和严重程度:一项横断面调查。
BMC Pediatr. 2022 Aug 2;22(1):463. doi: 10.1186/s12887-022-03520-x.
3
The asthma evidence base: a call for core outcomes in interventional trials.
哮喘证据基础:干预性试验中核心结局的呼吁。
J Asthma. 2021 Jul;58(7):855-864. doi: 10.1080/02770903.2020.1744641. Epub 2020 Apr 3.
4
Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide.慢性阻塞性肺疾病管理中患者报告的结局及考量:聚焦于茚达特罗/格隆溴铵
Patient Prefer Adherence. 2019 Jan 14;13:145-150. doi: 10.2147/PPA.S166704. eCollection 2019.
5
Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study.奥马珠单抗治疗对重度过敏性哮喘患者报告结局的改善:真实世界观察性PROXIMA研究
World Allergy Organ J. 2018 Nov 1;11(1):33. doi: 10.1186/s40413-018-0214-3. eCollection 2018.
6
Early Endotyping: A Chance for Intervention in Chronic Obstructive Pulmonary Disease.早期表型分型:慢性阻塞性肺疾病干预的机会。
Am J Respir Cell Mol Biol. 2018 Jul;59(1):13-17. doi: 10.1165/rcmb.2018-0002PS.